Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Revenue

Anika Therapeutics had revenue of $38.75M in the quarter ending September 30, 2024, a decrease of -6.54%. This brings the company's revenue in the last twelve months to $164.17M, up 0.52% year-over-year. In the year 2023, Anika Therapeutics had annual revenue of $166.66M with 6.67% growth.

• Revenue (ttm): $164.17M
• Revenue Growth: +0.52%
• P/S Ratio: 1.54
• Revenue / Employee: $459,854
• Employees: 357
• Market Cap: 251.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	166.66M	10.43M	6.67%
Dec 31, 2022	156.24M	8.44M	5.71%
Dec 31, 2021	147.79M	17.34M	13.29%
Dec 31, 2020	130.46M	15.85M	13.83%
Dec 31, 2019	114.61M	9.06M	8.58%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.